Upfront Immunotherapy for Metastatic Kidney Cancer
0 Bekeken
• 06/26/23
0
0
insluiten
administrator
abonnees
Panelists Robert A. Figlin, MD, and Eric Jonasch, MD, provide insight on the implications of frontline trials for immunotherapy and cabozantinib use, and the rationale for combination trials for metastatic kidney cancer.
Laat meer zien
Facebook Reacties
SORT BY-
Top Reacties
-
Laatste Reacties